PATENT CLAIM ANALYSIS

Application Number: 15906268
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "233200"]

Abstract:
The present invention is directed to novel compounds of formula I and their use as therapeutic compounds.

Claim (Index 24):
The pharmaceutical composition according to  claim 22  comprising a compound having formula Ih-2 or a pharmaceutically acceptable salt or solvate thereof and at least one pharmaceutically acceptable carrier, diluent, excipient and/or adjuvant, wherein a designates the bond linking R 1  to the piperazine moiety; and Ar 1 , R 1 , X 1  and X 2  are as defined in claim  2 ; and X 3  is as defined in claim  6 ; and R 14\u2033  is H or methyl; and X 4  is O, CH 2 , CF 2 , C(CH 3 ) 2 , N\u2014(C1-C3 alkyl) N-phenyl; and R 36a , R 36b , R 36\u2032a , R 37a  and R 37\u2032a  are independently selected from H, C1-C3 alkyl, alkoxyC1-C3 alkyl.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14349595', '14799208', '13627091', '15259922', '15205304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8096965827192383
- 35 USC 102 Novelty (BERT): 0.6420767883088525
- Combined Prediction Score: 0.7929346032781998
- Mean Citation Score: 548.391766
- Max Citation Score: 607.86743
- Similarity Product: 572.8264270838738

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test